These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17126660)

  • 1. Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
    Adabag AS; Kuskowski MA; Maron BJ
    Am J Cardiol; 2006 Dec; 98(11):1507-11. PubMed ID: 17126660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical outcomes of incidentally diagnosed hypertrophic cardiomyopathy.
    Efthimiadis GK; Parcharidou D; Pagourelias ED; Meditskou S; Spanos G; Hadjimiltiades S; Pliakos C; Gavrielides S; Karvounis H; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2010 May; 105(10):1445-50. PubMed ID: 20451692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy with longevity to 90 years or older.
    Maron BJ; Casey SA; Haas TS; Kitner CL; Garberich RF; Lesser JR
    Am J Cardiol; 2012 May; 109(9):1341-7. PubMed ID: 22381158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic features of exertional versus nonexertional sudden death in patients with hypertrophic cardiomyopathy.
    Tavora F; Cresswell N; Li L; Ripple M; Fowler D; Burke A
    Am J Cardiol; 2010 Feb; 105(4):532-7. PubMed ID: 20152250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Harrigan CJ; Appelbaum E; Maron BJ; Buros JL; Gibson CM; Lesser JR; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2008 Mar; 101(5):668-73. PubMed ID: 18308018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
    Efthimiadis GK; Parcharidou DG; Giannakoulas G; Pagourelias ED; Charalampidis P; Savvopoulos G; Ziakas A; Karvounis H; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2009 Sep; 104(5):695-9. PubMed ID: 19699347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sudden cardiac death in sports].
    Halle M; Wolfarth B
    MMW Fortschr Med; 2006 Jun; 148(23):38-40. PubMed ID: 16826736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
    Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].
    Colín Lizalde Lde J
    Arch Cardiol Mex; 2003; 73 Suppl 1():S26-30. PubMed ID: 12966640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility.
    Hipp AA; Heitkamp HC; Röcker K; Dickhuth HH
    Int J Sports Med; 2004 Jan; 25(1):20-6. PubMed ID: 14750008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual features of apical hypertrophic cardiomyopathy.
    Chung T; Yiannikas J; Freedman SB; Kritharides L
    Am J Cardiol; 2010 Mar; 105(6):879-83. PubMed ID: 20211337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic.
    Gimeno JR; Lacunza J; García-Alberola A; Cerdán MC; Oliva MJ; García-Molina E; López-Ruiz M; Castro F; González-Carrillo J; de la Morena G; Valdés M
    Am J Cardiol; 2009 Aug; 104(3):406-10. PubMed ID: 19616675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac magnetic field map topology quantified by Kullback-Leibler entropy identifies patients with hypertrophic cardiomyopathy.
    Schirdewan A; Gapelyuk A; Fischer R; Koch L; Schütt H; Zacharzowsky U; Dietz R; Thierfelder L; Wessel N
    Chaos; 2007 Mar; 17(1):015118. PubMed ID: 17411275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.